GnRH agonists before surgery for uterine leiomyomas: A review

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 41, Issue 6, 1996, Pages 415-421

  Crosignani, Pier Giorgio ^a   Vercellini, Paolo ^a   Meschìa, Michele ^a   Oldani, Sabina ^a   Bramante, Tiziana ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

gonadotropin releasing hormone; leiomyomas; uterine neoplasms

Indexed keywords

GONADORELIN AGONIST;

ADULT; AGED; AMENORRHEA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER SURGERY; CLINICAL ARTICLE; ESTROGEN BLOOD LEVEL; FEMALE; HUMAN; LEIOMYOMA; PREMEDICATION; PRIORITY JOURNAL; UTERUS TUMOR;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; FEMALE; GONADOTROPIN-RELEASING HORMONE; GOSERELIN; HUMANS; HYSTERECTOMY; LEIOMYOMA; LEUPROLIDE; PREOPERATIVE CARE; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 0029943189     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Buttram VC Jr, Reiter RC: Uterine leiomyomas: Etiology, symptomatology, and management. Fertil Steril 1981;36: 433-445
2. Vercellini P, Vendola N, Ragni G, et al: Abnormal uterine bleeding associated with iron-deficiency anemia: Etiology and role of hysteroscopy. J Reprod Med 1993;38:502-504
3. Moghissi KS: Hormonal therapy before surgical treatment for uterine leiomyomas. Surg Gynecol Obstet 1991;172:497-502
4. Candiani GB, Vercellini P, Fedele L, et al: Use of goserelin depot, a gonadotropin-releasing hormone agonist, for the treatment of menorrhagia and severe anemia in women with leiomyomas uteri. Acta Obstet Gynecol Scand 1990;69:413-415
5. Matta WHM, Stabile I, Shaw RW, et al: Doppler assessment of uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist Buserelin. Fertil Steril 1988;49:1083-1085
6. Friedman AJ: GnRH agonist therapy for uterine leiomyomas. In Gonadotropin Releasing Hormone Analogs: Applications in Gynecology. Edited by RL Barbieri, AJ Friedman. New York, Elsevier, 1991, pp 39-61
7. Friedman AJ: Use of gonadotropin-releasing hormone agonists before myomectomy. Clin Obstet Gynecol 1993;36:650-659
8. Feste J: Use of GnRH agonists in endoscopic and reproductive surgery. In Gonadotropin Releasing Hormone Analogs: Applications in Gynecology. Edited by RL Barbieri, AJ Friedman. New York, Elsevier, 1991, pp 103-119
9. Brooks PG: Hysteroscopic surgery using the resectoscope: Myomas, ablation, septae and synechiae: Does pre-operative medication help? Clin Obstet Gynecol 1992;35:249-255
10. Valle RF: Endometrial ablation for dysfunctional uterine bleeding: Role of GnRH agonists. Int J Gynecol Obstet 1993; 41:3-15
11. Friedman AJ, Rein MS, Harrison-Atlas D, et al: A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy. Fertil Steril 1989;52:728-733
12. Fedele L, Vercellini P, Bianchi S, et al: Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence. Br J Obstet Gynaecol 1990a;97: 393-396
13. Friedman AJ, Daly M, Juneau-Norcross M, et al: Recurrences of myomas after myomectomy in women pretreated with leuprolide acetate depot or placebo. Fertil Steril 1992;58:205-208
14. Hutchins FL Jr: Myomectomy after selective preoperative treatment with a gonadotropin releasing hormone analog. J Reprod Med 1992;37:699-702
15. Golan A, Bukovsky I, Pansky M, et al: Pre-operative gonadotrophin-releasing hormone agonist treatment in surgery for uterine leiomyomas. Hum Reprod 1993;8:450-452
16. Kiltz RJ, Rutgers J, Phillips J, et al: Absence of a dose-response effect of leuprolide acetate on leiomyomas uteri size. Fertil Steril 1994;61:1021-1026
17. Fedele L, Bianchi S, Baglioni A, et al: Intranasal buserelin versus surgery in the treatment of uterine leiomyomas: Long-term follow-up. Eur J Obstet Gynecol Reprod Biol 1990;38:53-57
18. Beyth Y: Gonadotropin-releasing hormone analog treatment should not precede conservative myomectomy (lett). Fertil Steril 1990;53:187-188
19. Coddington CC, Brzyski R, Hansen KA, et al: Short term treatment with leuprolide acetate is a successful adjunct to surgical therapy of leiomyomas of the uterus. Surg Gynecol Obstet 1992;175:57-63
20. Donnez J, Schrurs B, Gillerot S, et al: Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: Assessment by hysterography. Fertil Steril 1989;51: 947-950
21. Perino A, Chianchiano N, Petronio M, et al: Role of leuprolide acetate depot in hysteroscopic surgery: A controlled study. Fertil Steril 1993;59:507-510
22. Schneider D, Golan A, Bukovsky I, et al: GnRH analogue-induced uterine shrinkage enabling a vaginal hysterectomy and repair in large leiomyomatous uteri. Obstet Gynecol 1991;78:540-541
23. Sandy EA: The combined use of leuprolide acetate depot and laparoscopically assisted vaginal hysterectomy in the treatment of symptomatic uterine leiomyomas. J Gynecol Surg 1993;9:183-184
24. Stovall TG: Gonadotropin-releasing hormone agonists: Utilization before hysterectomy. Clin Obstet Gynecol 1993;36: 642-649
25. Lumsden MA, West CP, Baird DT: Goserelin therapy before surgery for uterine fibroids. Lancet 1987;1:36-37
26. Lumsden MA, West CP, Thomas E, et al: Treatment with the gonadotrophin releasing hormone-agonist goserelin before hysterectomy for uterine fibroids. Br J Obstet Gynaecol 1994;101:438-442
27. Stovall TG, Ling FW, Henry LC, et al: A randomized trial evaluating leuprolide acetate before hysterectomy as treatment for leiomyomas. Am J Obstet Gynecol 1991;164:1420-1425
28. Stovall TG, Summit RL, Washburn SA, et al: Gonadotropin-releasing hormone agonist use before hysterectomy. Am J Obstet Gynecol 1994;170:1744-1751
29. Audebert AJM, Madenelat P, Querleu D, et al: Defered versus immediate surgery for uterine fibroids: Clinical trial results. Br J Obstet Gynaecol (suppl 10) 1994;101:29-32
30. Vercellini P, Vendola N, Bocciolone L, et al: Gonadotropin releasing hormone agonist treatment before hysterectomy for menorrhagia associated with uterine myomas. Acta Obstet Gynecol Scand 1993;72:369-373
31. Friedman AJ: Combined oestrogen-progestin treatment of vaginal haemorrhage following gonadotropin-releasing hormone agonist therapy of uterine myomas. Hum Reprod 1993;8:540-542
32. Vercellini P, Crosignani PG: Zoladex and the anaemic patient. Br J Obstet Gynaecol (suppl 10) 1994;101:33-37
33. Candiani GB, Ferrari AG: Isterectomia Vaginale. Milan, Massen Italia, 1986
34. Kovak SR: Intramyometrial coring as an adjunct to vaginal hysterectomy. Obstet Gynecol 1986;67:131-136
35. Gitsch G, Berger E, Tatra G: Complications of vaginal hysterectomy under difficult circumstances. Arch Gynecol Obstet 1991;249:209-212
36. Reiter RC, Wagner PL, Gambone JC: Routine hysterectomy for large asymptomatic uterine leiomyomas: A reappraisal. Obstet Gynecol 1992;79:481-484
37. Vercellini P, Ragni G, Colombo A, et al: Gonadotropin releasing hormone agonist treatment before hysteroscopic metroplasty. Gynaecol Endosc 1993;2:153-157
38. Vercellini P, Trespidi L, Bramante T, et al: Gonadotropin releasing hormone agonist treatment before hysteroscopic endometrial resection. Int J Gynecol Obstet 1994;45:235-239